In a retrospective analysis five of 104 patients with acute leukaemia undergoing cytotoxic chemotherapy developed abdominal signs requiring emergency surgical exploration. Two common features in these patients were the inclusion of cytosine arabinoside in their treatment regimen and a necrotizing lesion involving the terminal ileum, appendix, and right colon. Appendicectomy was performed in two and hemicolectomy in three. Ofthe patients receiving high-dose cytosine arabinoside one died in the immediate post-operative period and two after recovery from surgery but before marrow regeneration; the remaining two patients received conventional dose cytosine arabinoside, and both recovered. The inclusion of this agent is standard in modern treatment programmes, resulting in significant improvement in longterm disease-free survival, so that a greater awareness of this complication is necessary. Early surgery, utilizing modern support techniques, is recommended as feasible and appears to offer the only realistic chance of survival.
Introduction
The development of an acute surgical abdomen during the pancytopenic period following the administration of cytotoxic chemotherapy for leukaemia is well recognized (Seligman et al., 1972; Steinberg et al., 1973; Sherman & Woolley, 1973; Rasmussen & Freeman, 1975; Exelby et al., 1975; Varki et al., 1979; Kies et al., 1979; Lehman & Armitage, 1980; Yates et al., 1982; Mackinnon et al., 1982; Jones & Abramson, 1983) . In addition to coincidental causes such as acute appendicitis, a specific syndrome of necrotizing enterocolitis has been recognized (Steinberg et al., 1973; Sherman & Woolley, 1973) . In view of the steadily improving results for long-term disease-free survival and possible cure in acute leukaemia (Jacobs & Gale, 1984; Lister & Rohatine, 1982) , it is important to be aware of this complication, with management centred on early surgical exploration and intensive support which includes an appropriate antibiotic regimen and effective granulocyte and platelet transfusions. Considering the extremely poor prognosis of this syndrome (Steinberg et al., 1973; Sherman & Woolley, 1973; Yates et al., 1982) and evidence that surgical management offers an alternative option (Rasmussen & Freeman, 1975; Exelby et al., 1975; Lehman & Armitage, 1980) , we present our experience with five such consecutive patients. 
Results
The incidence of patients requiring major abdominal surgery in this group was 5%. The clinical and laboratory features are summarized in Table I . There were four males and one female, with a mean age of 33.8 years (range 14-62 years). Three had a diagnosis of acute myeloblastic and two of acute lymphoblastic leukaemia. All were severely neutropenic and thrombocytopenic at the time of presentation with their abdominal symptoms. All had received extensive prior chemotherapy. Patients 1 to 4 had leukaemia refractory to standard induction regimens, while patient 5 was in a second remission and receiving consolidation chemotherapy. Blood cultures yielded either negative results or growth of contaminant organisms and were consequently not helpful in guiding the choice of antibiotics.
The details of the acute abdominal presentation are summarized in Table II . All patients had the onset of symptoms within an average of 8 days (range 3-13 days) of commencing chemotherapy. A variety of chemotherapeutic agents were given, but cytosine arabinoside was common to all the programmes. Two patients (Nos. 1 and 5) received conventional doses, while patients 2, 3 and 4 received high-dose cytosine arabinoside defined as 3 g/m2 every 12 hours for 6 days in patient 2 and 2 g/m2 every 12 hours for 5 days in patients 3 and 4. The clinical presentation in all patients was that ofa surgical abdomen, characterized by acute onset of colicky pain associated with fever and frequently with diarrhoea, which was blood stained in one patient (No. 4). Three patients had nausea with vomiting. Abdominal examination revealed signs of peritoneal irritation, generalized in three, but more localized to the right lower quadrant in two. Radiographic findings in two patients were consistent with the presence of a paralytic ileus. Findings at laparotomy (Table II) included nonspecific haemorrhagic or gangrenous bowel in four, with acute appendicitis in one. In three patients the surgeon performed right hemicolectomy, and in two the appendix was removed. Two patients who received conventional doses of cytosine arabinoside recovered fully simultaneously with marrow regeneration. The three patients who received high-dose cytosine arabinoside died within 2 weeks. Although patients 2 and 4 had recovered from surgery, their deaths were associated with the complications of prolonged marrow aplasia, while patient 3 died shortly after surgery.
Discussion
The incidence of patients requiring major abdominal surgery in this series is 5%, which approximates closely to that reported by others (Wagner et al., 1970; Steinberg et al., 1973; Exelby et al., 1975; Yates et al., 1982) , although the development of an acute abdomen has been reported to occur in as many as 28% of patients with acute leukaemia (Jones & Abramson, 1983) . The clinical presentation of these five patients was characteristic and included, within several days of receiving chemotherapy, the appearance of fever, vomiting, diarrhoea, gastrointestinal bleeding, abdominal peritonitis, with localization in the right lower quadrant of the abdomen. Radiographic changes are usually not specific (Wagner et al., 1970; Exelby et al., 1975) . This syndrome, which has been variously labelled as typhlitis (Wagner et al., 1970; Varki et al., 1979) , neutropenic enterocolitis (Kies et al., 1979) , the ileocaecal syndrome (Sherman & Woolley, 1973) , and necrotizing enterocolitis (Steinberg et al.. 1973; Yates et al., 1982) should now be sufficiently well characterized, occurring frequently in patients with acute leukaemia who are receiving intensive induction or consolidation chemotherapy during the phase of temporary marrow aplasia with peripheral blood granulocytopenia and thrombocytopenia.
The pathogenesis is not clear, although primary gut necrosis with secondary infection appears to be the likeliest explanation (Leach et al., 1969; Slavin et al., 1978) . The reason for the frequent involvement of the caecum and ascending colon is obscure. The syndrome seems to be most frequently associated with the use of cytosine arabinoside and an anthracycline (Yates et al., 1982; Jones & Abramson, 1983) , although it has been reported following a variety of other chemotherapeutic regimens. The present series is remarkable for the association of the syndrome with the prior or concomitant administration of high-dose cytosine arabinoside (Johnson et al., 1985) . Prolonged marrow aplasia is a feature of this chemotherapy programme and although two of the patients recovered from the surgery, survival ultimately depends also on the return of peripheral circulating granulocytes and platelets.
The management of this catastrophic complication has been controversial (Johnson et al., 1985) , and although recovery without surgical intervention is exceptional (Table 111 ), survival appears to depend on a combination of well planned surgery with recovery of bone marrow function. The role of broad spectrum antibiotics, with platelet and granulocyte transfusions, has contributed significantly to the support of the patient during the post-operative period until marrow 
recovery occurs, and is probably the reason for the increasing proportion of patients who survive and recover from surgery (Table III) .
Conclusions
Five patients who developed an acute surgical abdomen while receiving chemotherapy for acute leukaemia are reported. The syndrome of necrotizing colitis is characterized, and its association with the use of high-dose cytosine arabinoside has been noted. An approach to management utilizing modem supportive facilities together with surgical intervention appears to offer the only chance of survival. This attitude is considered worthwhile in view of the improved long-term outlook in patients with acute leukaemia, many of whom may now be cured.
